INTERPRETATION SMC is a major factor influencing gross motor function in individuals with CP. Lower limb muscle volume and spasticity also influence gross motor function.
Although individuals with cerebral palsy (CP) experience a range of impairments including muscle contractures and spasticity, variation in gross motor function can be explained only to a limited extent in terms of these impairments. 1, 2 Identifying the major factors influencing gross motor function is important for the design and prescription of clinical interventions aimed at improving an individual's functional ability.
Muscle strength is a product of an individual's ability to activate muscles and the intrinsic properties of those muscles. Of the intrinsic properties of muscle that influence muscle strength, muscle size is a major factor in children, 3, 4 adolescents, 5 and adults. 5, 6 Although muscle strength has previously been shown to be a moderate predictor of gross motor function in children with bilateral CP, 7 the strength of this relationship is likely to be influenced by the difficulty in assessing strength in this group. Since selective motor control (SMC) is reduced in individuals with CP, 8, 9 measuring maximum voluntary contraction force may not be reflective of forces developed during routine or habitual activities. Therefore, to aid our understanding of the wide variation in motor function in individuals with CP, it makes sense to seek an explanation in terms of their motor control and their muscle size.
In 2009, a validated test of SMC was introduced. 10 Selective Control Assessment of the Lower Extremity (SCALE) is an assessment of all the major joints of the lower limb. SCALE has previously been reported to correlate with knee flexion at initial contact in gait, 11, 12 with ability to perform uncoupled hip and knee movement during swing phase of gait, 13 and with overall gait profile score. 7 However, to date the relationship between SCALE and Gross Motor Function Measure (GMFM) has not been published. Since the GMFM requires the participant to perform a series of non-habitual movements, many of which require antigravity strength, stronger correlations would be expected between GMFM and SCALE compared to those reported with gait. Together with muscle size, other aspects of an upper motor neuron lesion, such as spasticity, might also influence gross motor function. The Modified Ashworth Scale (MAS) has been used in research studies and is commonly reported in clinics for assessing spasticity. For children with CP, GMFM has been shown to be moderately related to MAS. 1 In this preliminary study we investigate the relationship between muscle volume, SMC (SCALE), and spasticity (MAS) on gross motor function (GMFM-66) in adolescents and young adults with bilateral spastic CP to improve our understanding of the factors influencing gross motor function. MAS has been included in this study together with muscle volume and SCALE because of its previously reported relationship with GMFM, and its widespread clinical use when assessing children with CP. We hypothesize that in this small preliminary study SCALE and total lower limb muscle volume will be significantly related to GMFM-66, but MAS will not be significantly related to GMFM-66.
METHOD Participants
The National Research Ethics Committee London, West London granted ethical approval for this study. Individuals aged 12 years to 25 years, with a diagnosis of bilateral spastic CP, Gross Motor Function Classification System (GMFCS) levels I to IV, who met the safety requirements of magnetic resonance imaging (MRI) were included in this study. Patients who had undergone surgery, serial casting, or botulinum neurotoxin injections to the lower limbs within the previous year were excluded from the study. This was a convenience sample of individuals attending the gait clinic at our hospital, with consecutive patients that met the inclusion criteria invited to participate in the study. The age range and GMFCS levels in the inclusion criteria were chosen to reflect our clinical population to maximize recruitment for this preliminary study. At our clinic, we see children over 4 years of age and young adults in GMFCS levels I to IV. However, the lower age for potential participants was set at 12 years because of the difficulties younger children may have coping and complying with the requirements of undergoing an MRI. Eleven male adolescents and young adults with bilateral spastic CP (mean age 15y 7mo, standard deviation 3y 6mo, range 12y 1mo-23y 1mo, GMFCS level I [n=1], GMFCS level II [n=5], GMFCS level III [n=4], and GMFCS level IV [n=1]) took part in this study. All participants (or their guardians if <16y) gave informed consent to take part in this study and the publication of the data. MRI data from eight of the 11 participants have previously been reported in a study investigating the relationship between muscle size and bone strength in individuals with CP. 14 
Data collection and analysis
Magnetic resonance images were acquired on a 3.0T Achieva system (Philips Medical Systems, Best, the Netherlands), with a quadrature body coil. MRI of both lower limbs of all participants were acquired with contiguous transverse slices from above the iliac crest to below the calcaneum. All participants laid supine on the scanner bed with their feet resting against a wooden footplate giving an approximate plantarflexion angle of 25°. A three-point mDixon sequence (echo time/repetition time=2.11/5.2ms, echo time shift=0.76ms [120°echo phase shift], 10°flip angle, 1.291.2mm in-plane voxel size, number of averages=2, 5mm slice thickness) was acquired of both lower limbs. Muscle volumes were manually segmented by a single assessor in Osirix (version 5.8.2; Pixmeo, Geneva, Switzerland) for 18 muscles in both legs (medial gastrocnemius, lateral gastrocnemius, soleus, tibialis anterior, tibialis posterior, vastus medialis, rectus femoris, vastus intermedius and lateralis composite, semimembranosus, semtendinosus, gracilis, sartorius, biceps femoris long and short head, adductors composite, gluteus maximus, gluteus medius, and gluteus minimus). For each muscle measured, muscle volumes were averaged between limbs and normalized to body mass. These limb-averaged muscle volumes normalized to body mass were then summed to produce a measure of the combined lower limb muscle volume normalized to body mass for each individual. To assess the interassessor test-retest repeatability of the muscle volume measurement technique, the muscle volume measurement was performed by two assessors for five muscles (medial gastrocnemius, soleus, semitendinosus, rectus femoris, and gluteus maximus) in five participants (three participants with bilateral spastic CP that took part in this study and two typically developing participants), with the second assessor blinded to the results of the first. These five muscles were chosen because of the range in difficulty in assessing muscle boundaries in the MRI and their varying shape and size so that the muscles assessed in the repeatability study were representative of the larger group of muscles investigated in this study. SMC was assessed using SCALE 10 with the summed total score out of 20 that included the hip, knee, and ankle of both lower limbs. Spasticity was assessed using the MAS 15 with the total score formed from the summation of the individual scores at the hip, knee, and ankle for both lower limbs. Gross motor functional ability was assessed using the GMFM-66. 16 SCALE, MAS, and GMFM-66 were assessed on the same day as each volunteer's MRI appointment by the same experienced physiotherapist.
Statistical analysis
Shapiro-Wilks test of normality was conducted on GMFM-66 and all factors: MAS, SCALE, and lower limb muscle volume normalized to body mass. For the factors that were normally distributed, Pearson's rank correlation coefficients were used to investigate relationships between the factors and GMFM-66. For any factor that was not normally distributed, the non-parametric Spearman's rank correlation coefficient was performed. Interassessor reliability of muscle volume measurement was examined using a one-way intraclass correlation coefficient reporting single measure reliability. The intraclass correlation coefficient scores will be categorized by the benchmarks for intraclass correlation coefficient proposed by Landis and Koch: 17 0 to 0.2 'poor'; 0.21 to 0.40 'fair'; 0.41 to 0.60 'moderate'; 0.61 to 0.80 'substantial'; and 0.81 to 1.00 'almost perfect'.
What this paper adds
• Selective motor control is a major factor of gross motor function in adolescents and young adults with bilateral cerebral palsy (CP).
• Gross motor function is related to muscle size and level of spasticity in adolescents and young adults with bilateral CP.
The standard error of measurement was calculated as SD diff 9√(1ÀICC) (where SD diff is the standard deviation of the differences between the repeated measures). All statistical tests were performed using SPSS version 20.0 (IBM Corp., Armonk, NY, USA) with significance set to a p-value of 0.05 or lower.
RESULTS
The physical characteristics of the participants are summarized in Table I , with the age and GMFCS level for each participant given in Table II. Table III summarizes the results of the test-retest consistency of the muscle volume analysis technique. 'Almost perfect' intraclass correlation coefficients ranging from 0.994 to 0.998 were observed for the muscles investigated.
The scatter plots of GMFM-66 against SCALE, MAS, and lower limb muscle volume normalized to body are given in Figure 1 . GMFM-66, SCALE, and lower limb muscle volume normalized to body mass were all normally distributed (p=0.774, p=0.178, and p=0.964 respectively). Therefore, a Pearson's rank correlation coefficient was utilized to investigate the relationship between these variables. GMFM-66 was strongly positively correlated to SCALE (r=0.901, p≤0.001) and lower limb muscle volume normalized to body mass (r=0.750, p=0.008). Lower limb muscle volume normalized to body mass was not significantly related to SCALE (r=0.545, p=0.083).
MAS was not normally distributed (p=0.036), and therefore Spearman's rank correlation coefficient was performed between MAS and the other variables. MAS was significantly correlated with GMFM-66 (r s =À0.691, p=0.018), but was not significantly correlated with SCALE (r s =À0.511, p=0.108) or lower limb muscle volume normalized to body mass (r s =À0.358, p=0.280).
DISCUSSION
As hypothesized, GMFM-66 was significantly positively related to SCALE and to lower limb muscle volume normalized to body mass. These preliminary results suggest that lower limb muscle volume and SMC are significant factors that limit gross motor function in ambulant individuals with bilateral spastic CP.
It has previously been shown that muscles in children with CP increase in size after a muscle strengthening intervention. 18 The strong relationship between muscle size and GMFM-66 observed in this study suggests that performing muscle-strengthening exercises to increase muscle size in this group may potentially lead to an increase in gross motor function. However, in the literature, gross motor function is not consistently improved after a muscle strengthening intervention. This inconsistent finding may be explained by the stronger correlation observed between SCALE and GMFM-66 compared to muscle volume normalized to body mass in this study, with any potential gains in gross motor function because of increased muscle size/strength being tempered by the individual's SMC. The negative impact of reduced SMC on an individual's ability to perform a muscle strength training programme may also in part explain the limited improvements in functional ability that occur after lower limb resistance training in CP. 19, 20 Overall, the results of this study suggest that neural control is more important in determining an individual's functional ability than their lower limb muscle strength. A larger, longitudinal study investigating the effect of a muscle-strengthening programme on GMFM-66 is required to determine the interactions between SMC and muscle size/strength with gross motor function and muscle strengthening interventions. In this study GMFM-66 was significantly related to MAS. This was a surprising result considering the low participant numbers and the widespread criticism of MAS in the literature, particularly in validity of the MAS for measuring spasticity 21, 22 because of its inability to distinguish between resistance to stretch resulting from altered mechanical properties of the muscle and alterations in the neuromuscular system. The significant correlation observed between GMFM-66 and MAS in this study suggests that increased resistance to movement at a joint is a significant factor influencing gross motor function; however, because of the limitations in the MAS, it is not known whether this finding is related to mechanical or neuromuscular factors.
Study limitations
The low participant numbers in this preliminary study limits its statistical power. However, the strong predictive nature of SCALE and lower limb muscle volume normalized to body mass on the GMFM-66 suggests that SMC and lower limb muscle volume are the significant factors limiting gross motor function in ambulant individuals with bilateral spastic CP. The statistical power of the study can be investigated using a retrospective sample size calculation. For a statistical significance (a) of 0.05, probability of making type II errors (b) of 0.1 (a power of 0.9), and effect size (linear regression coefficient r) of 0.8, a sample size of 10 is required. 23 For an effect size r of 0.7, a sample size of 14 is required for a power of 0.9, or 11 for a power of 0.8. This suggests that the sample size of 11 participants that participated in this study has provided a statistical power of >0.9 for the relationship between SCALE and GMFM (r=0.901), and a statistical power of >0.8 for the relationship between muscle volume and GMFM (r=0.750). 23 These statistical powers mean that despite the low participant numbers in this study, the results can be reported with confidence. To investigate whether the investigated variables can be utilized to predict GMFM-66, a larger study is required.
The participants in this study were aged 12 to 23 years. As sexual development was not assessed as part of this study, it is possible that some individuals who participated in the study were prepubescent. Any changes in muscle volume relative to body mass during puberty will add variation to the data set depending on the variable pubertal stage of the volunteers in the study. Despite this, a strong positive correlation (r=0.75) was observed between GMFM and lower limb muscle volume normalized to body mass. However, as the participants were older than 12 years, and therefore likely to be postpubescent, caution should be used when generalizing the results of this study as the relationship between GMFM and muscle volume normalized to body mass, SCALE, or MAS may be different for individuals aged younger than 12 years.
Using the MAS to assess spasticity is also a limitation of the study. As discussed above, the validity of the MAS for measuring spasticity has been questioned in the literature. 21, 22 Therefore, the moderate correlation observed between MAS and GMFM-66 is unlikely to be a true assessment of the relationship between spasticity and gross motor function. Modified Ashworth Scale was performed in this study as an indicator of spasticity levels considering the strong correlations between spasticity and gross motor function reported in previous studies, 1, 24 and the widespread clinical use of MAS to assess spasticity. More sophisticated measures of spasticity are required to further elucidate the relationship between spasticity and gross motor function.
Muscle volume was assessed by manually drawing regions of interest around the muscles of interest. This method is time-consuming and will be assessor dependent. Although the analysis of the interassessor of repeatability was 'almost perfect', a relatively high percentage standard deviation of 5.47% was observed for semitendinosus between the assessors. Considering total lower limb muscle volume is investigated here, an automated technique for measuring total muscle volume would be more appropriate compared to performing manual segmentation of individual muscles and summing the volumes measured.
CONCLUSION
Gross motor function was related to SCALE, lower limb muscle volume normalized to body mass, and MAS was significantly correlated with GMFM-66 in a small group of individuals with bilateral spastic CP. The stronger relationship observed for SCALE with GMFM compared to normalized muscle volume and MAS suggests that SMC is the dominant factor over muscle size and joint stiffness in determining an individual's gross motor function.
